Joep F W M Bartelsman
Overview
Explore the profile of Joep F W M Bartelsman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
3011
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bennebroek Evertsz F, Sprangers M, Sitnikova K, Stokkers P, Ponsioen C, Bartelsman J, et al.
J Consult Clin Psychol
. 2017 Sep;
85(9):918-925.
PMID: 28857595
Objective: Inflammatory bowel disease (IBD) is characterized by a low level of quality of life (QoL) and a high prevalence of anxiety and depression, especially in patients with poor QoL....
2.
van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal E, de Vos W, et al.
N Engl J Med
. 2013 Jan;
368(5):407-15.
PMID: 23323867
Background: Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high. We studied the effect of duodenal infusion of donor feces in patients with...
3.
Vrieze A, van Nood E, Holleman F, Salojarvi J, Kootte R, Bartelsman J, et al.
Gastroenterology
. 2012 Jun;
143(4):913-6.e7.
PMID: 22728514
Alterations in intestinal microbiota are associated with obesity and insulin resistance. We studied the effects of infusing intestinal microbiota from lean donors to male recipients with metabolic syndrome on the...
4.
Boparai K, Dekker E, van Eeden S, Polak M, Bartelsman J, Mathus-Vliegen E, et al.
Gastroenterology
. 2008 Nov;
135(6):2014-8.
PMID: 19013464
Background & Aims: MYH-associated polyposis (MAP) is a disorder caused by a bi-allelic germline MYH mutation, characterized by multiple colorectal adenomas. These adenomas typically harbor G:C-->T:A transversions in the APC...
5.
Deurloo J, Ekkelkamp S, Taminiau J, Kneepkens C, ten Kate F, Bartelsman J, et al.
J Pediatr Surg
. 2005 Aug;
40(8):1227-31.
PMID: 16080923
Background: Gastroesophageal reflux is a frequent problem after esophageal atresia (EA) repair. Our aim was to determine the prevalence of esophagitis and Barrett esophagus more than 10 years after repair...
6.
Mulder C, Bartelsman J
Best Pract Res Clin Gastroenterol
. 2005 Jun;
19(3):479-86.
PMID: 15925851
Large-scale screening studies on CD have been published and suggest a prevalence of CD in USA, Europe, Middle-East and Australia of about 1:100. The costs of finding coeliacs hasn't been...
7.
Homs M, Steyerberg E, Eijkenboom W, Tilanus H, Stalpers L, Bartelsman J, et al.
Lancet
. 2004 Oct;
364(9444):1497-504.
PMID: 15500894
Background: Both single-dose brachytherapy and self-expanding metal stent placement are commonly used for palliation of oesophageal obstruction due to inoperable cancer, but their relative merits are unknown. We undertook a...
8.
Deurloo J, Ekkelkamp S, Bartelsman J, Ten Kate F, Schoorl M, Heij H, et al.
Ann Surg
. 2003 Oct;
238(5):686-9.
PMID: 14578730
Objective: To study the incidence of gastroesophageal reflux (GER)related complications after correction of esophageal atresia (EA). Summary Background Data: The association of EA and GER in children is well known....
9.
van Lent A, Bartelsman J, Tytgat G, Speelman P, Prins J
Gastrointest Endosc
. 2002 Mar;
55(4):518-22.
PMID: 11923764
Background: Drainage of the obstructed biliary tree is the mainstay of therapy for patients with acute cholangitis; antibiotic therapy is complementary. It is unknown whether it is necessary to continue...
10.
Hommes D, van de Heisteeg B, van der Spek M, Bartelsman J, van Deventer S
Inflamm Bowel Dis
. 2002 Feb;
8(2):81-6.
PMID: 11854604
The aim of this study was to report the 1-year clinical experience with infliximab treatment for Crohn's disease (CD) in the Netherlands. All 73 CD patients receiving infliximab infusions were...